HC Wainwright & Co. Maintains Buy on Balchem, Lowers Price Target to $135
BenzingaOct 30, 2023 06:53 ET
Balchem Analyst Ratings
BenzingaOct 30, 2023 06:51 ET
HC Wainwright & Co. Maintains Buy on Balchem, Raises Price Target to $165
BenzingaJul 31, 2023 06:13 ET
Balchem Analyst Ratings
BenzingaJul 31, 2023 06:13 ET
HC Wainwright Adjusts Price Target on Balchem to $150 From $140, Keeps Buy Rating
MT NewswiresJun 5, 2023 08:01 ET
Analysts Offer Insights on Healthcare Companies: Agenus (AGEN) and Balchem (BCPC)
TipRanksJun 5, 2023 06:20 ET
HC Wainwright & Co. Maintains Buy on Balchem, Raises Price Target to $150
BenzingaJun 5, 2023 06:08 ET
HC Wainwright Adjusts Price Target on Balchem to $140 From $152, Keeps Buy Rating
MT NewswiresFeb 27, 2023 09:15 ET
HC Wainwright & Co. Maintains Buy on Balchem, Lowers Price Target to $140
BenzingaFeb 27, 2023 06:11 ET
HC Wainwright Adjusts Price Target on Balchem to $152 From $164, Maintains Buy Rating
MT NewswiresNov 7, 2022 09:45 ET
Balchem Analyst Ratings
Benzinga Analyst RatingsNov 7, 2022 06:42 ET
HC Wainwright & Co. Maintains Buy on Balchem, Lowers Price Target to $152
Benzinga Real-time NewsNov 7, 2022 06:41 ET
H.C. Wainwright Sticks to Its Buy Rating for Balchem (BCPC)
TipRanksNov 7, 2022 06:30 ET
Balchem (BCPC) Gets a Buy From H.C. Wainwright
TipRanksSep 1, 2022 06:20 ET
Balchem Is Maintained at Buy by HC Wainwright & Co.
Dow JonesAug 22, 2022 06:28 ET
Balchem Price Target Raised to $164.00/Share From $152.00 by HC Wainwright & Co.
Dow JonesAug 22, 2022 06:28 ET
HC Wainwright Adjusts Balchem's Price Target to $164 From $152, Reiterates Buy Rating
MT NewswiresAug 22, 2022 06:24 ET
H.C. Wainwright Remains a Buy on Balchem (BCPC)
TipRanksAug 22, 2022 06:20 ET
Balchem Analyst Ratings
Benzinga Analyst RatingsAug 22, 2022 06:18 ET
No Data
No Data